These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 6463046
21. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. Bloom JW, Halonen M, Lawrence LJ, Rould E, Seaver NA, Yamamura HI. J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397 [Abstract] [Full Text] [Related]
22. Loss of D1 and D2 dopamine receptors and muscarinic cholinergic receptors in rat brain following in vitro polytron homogenization. Norman AB, Borchers MT, Wachendorf TJ, Price AL, Sanberg PR. Brain Res Bull; 1989 Apr; 22(4):633-6. PubMed ID: 2660951 [Abstract] [Full Text] [Related]
23. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport. Zimmerman TW, Binder HJ. Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277 [Abstract] [Full Text] [Related]
28. Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex. Adem A, Sabbagh M, Nordberg A. J Neural Transm; 1988 Apr 25; 72(1):11-8. PubMed ID: 3379385 [Abstract] [Full Text] [Related]
29. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons. Dawson VL, Dawson TM, Wamsley JK. Brain Res Bull; 1990 Dec 25; 25(6):903-12. PubMed ID: 2149667 [Abstract] [Full Text] [Related]
31. Effect of repeated administration of manganese on the striatal cholinergic and dopaminergic receptors in the rat. Bhargava HN. Toxicol Lett; 1987 Jul 25; 37(2):135-41. PubMed ID: 3603588 [Abstract] [Full Text] [Related]
32. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR, Wolfe BB. J Pharmacol Exp Ther; 1985 Jul 25; 234(1):37-44. PubMed ID: 3839265 [Abstract] [Full Text] [Related]
33. Muscarinic antagonist binding to intact rat thymocytes. Maslinski W, Grabczewska E, Bartfai T, Ryzewski J. Acta Chem Scand (Cph); 1990 Feb 25; 44(2):147-51. PubMed ID: 2206705 [Abstract] [Full Text] [Related]
34. Quantitative and qualitative differences in muscarinic cholinergic receptors in embryonic and newborn chick hearts. Hosey MM, Fields JZ. J Biol Chem; 1981 Jun 25; 256(12):6395-9. PubMed ID: 7240213 [Abstract] [Full Text] [Related]
35. Effects of deoxyribonuclease I and neuraminidase treatments on the specific binding of 3H-prazosin and 3H-quinuclidinyl benzilate (3H-QNB) to alpha-adrenergic and muscarinic receptors in rat myocardial membranes. Nagatomo T, Tsuchihashi H, Imai S. Jpn J Pharmacol; 1986 May 25; 41(1):135-8. PubMed ID: 3016391 [Abstract] [Full Text] [Related]
36. Stereospecific 3H-QNB binding to human erythrocyte membranes associated with muscarinic cholinergic receptors. Bering B, Müller WE. J Neural Transm; 1987 May 25; 68(1-2):97-111. PubMed ID: 3806087 [Abstract] [Full Text] [Related]
37. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR, Wolfe BB. J Pharmacol Exp Ther; 1984 Mar 25; 228(3):648-55. PubMed ID: 6546770 [Abstract] [Full Text] [Related]